Survodutide

Survodutide (BI 456906) Research Standard

Survodutide (BI 456906) is a synthetic dual agonist peptide targeting both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). By engaging these two distinct yet complementary signaling pathways, Survodutide offers a multifaceted approach to studying metabolic control. In laboratory and analytical research, it serves as a critical reference tool for investigating the synergistic effects of multi-incretin pathway modulation on appetite regulation, energy expenditure, and lipid utilization.

Technical Specifications

Mechanism of Action & Research Context

Survodutide is designed to mimic the integrated signaling of metabolic hormones, focusing on the interplay between satiety and energy expenditure.

• GLP-1 Receptor Agonism: Interaction with GLP-1R is investigated for its role in modulating central appetite regulation, satiety signaling, and the support of glucose-dependent insulin pathways.

• Glucagon Receptor Agonism: Simultaneously, GCGR activation is probed for its specific contributions to increasing energy expenditure, enhancing lipid utilization, and refining hepatic metabolic signaling.

• Dual-Agonist Synergy: The laboratory research significance of Survodutide lies in the potential synergy between these two pathways. This provides a mechanism to study metabolic outcomes that are distinct from those observed in models utilizing single-pathway incretin analogs.

Research Applications

Survodutide is a specialized reagent essential for modern metabolic, endocrine, and pharmacological research.

Primary fields of in vitro and translational laboratory investigation include:

• Metabolic Control Pathways: Analyzing the dual activation of GLP-1R and GCGR and their downstream effects on metabolic homeostasis.

• Energy Expenditure Research: Quantifying the increase in metabolic efficiency and lipid utilization in cellular models of obesity and metabolic syndrome.

• Comparative Incretin Studies: Serving as a comparative benchmark to distinguish the effects of dual-agonism against GLP-1-only peptides.

• Hepatic Metabolism: Probing the role of glucagon receptor signaling in hepatic lipid handling and glucose regulation.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the peptide:

• Storage Environment: Store the lyophilized powder in a dry, cool environment. Maintain at temperatures below 0°C (typically -20°C) for long-term stability.

• Environmental Control: Protect strictly from direct light and moisture to prevent the degradation of the peptide sequence.

• Reconstitution: Use sterile, buffered aqueous solutions for reconstitution. Aliquot the solution immediately to minimize freeze-thaw cycles.

• Aseptic Technique: Utilize clean, sterile laboratory equipment in a controlled environment to ensure experimental accuracy and prevent enzymatic contamination.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.